Blood pressure screening in midlife aids in prediction of dementia later in life.

Midlife hypertension dementia long-term follow-up prediction prevalence screening

Journal

Upsala journal of medical sciences
ISSN: 2000-1967
Titre abrégé: Ups J Med Sci
Pays: Sweden
ID NLM: 0332203

Informations de publication

Date de publication:
2022
Historique:
received: 30 04 2021
revised: 06 10 2021
accepted: 07 11 2021
entrez: 10 2 2022
pubmed: 11 2 2022
medline: 12 2 2022
Statut: epublish

Résumé

There is substantial evidence that midlife hypertension is a risk factor for late life dementia. Our aim was to investigate if even high blood pressure at a single timepoint in midlife can predict an increased risk for all-cause dementia, Alzheimer's disease (AD), or vascular dementia (VaD) later in life. The community-based study population comprised 30,102 dementia-free individuals from the After a mean follow-up time of 24 years resulting in 662,244 person/years, 761 (2.5%) individuals had been diagnosed with dementia. Midlife high blood pressure at a single timepoint predicted all-cause dementia (hazard ratio [HR]: 1.22, 95% confidence interval [CI]: 1.02-1.45) and VaD (HR: 2.10, 95% CI: 1.47-3.00) but not AD (HR: 1.06, 95% CI: 0.81-1.38). This study suggests that even midlife high blood pressure at a single timepoint predicts all-cause dementia and more than doubles the risk for VaD later in life independently of established confounders. Even though there was no such association with AD, this strengthens the importance of midlife health examinations in order to identify individuals with hypertension and initiate treatment.

Sections du résumé

BACKGROUND BACKGROUND
There is substantial evidence that midlife hypertension is a risk factor for late life dementia. Our aim was to investigate if even high blood pressure at a single timepoint in midlife can predict an increased risk for all-cause dementia, Alzheimer's disease (AD), or vascular dementia (VaD) later in life.
METHODS METHODS
The community-based study population comprised 30,102 dementia-free individuals from the
RESULTS RESULTS
After a mean follow-up time of 24 years resulting in 662,244 person/years, 761 (2.5%) individuals had been diagnosed with dementia. Midlife high blood pressure at a single timepoint predicted all-cause dementia (hazard ratio [HR]: 1.22, 95% confidence interval [CI]: 1.02-1.45) and VaD (HR: 2.10, 95% CI: 1.47-3.00) but not AD (HR: 1.06, 95% CI: 0.81-1.38).
CONCLUSION CONCLUSIONS
This study suggests that even midlife high blood pressure at a single timepoint predicts all-cause dementia and more than doubles the risk for VaD later in life independently of established confounders. Even though there was no such association with AD, this strengthens the importance of midlife health examinations in order to identify individuals with hypertension and initiate treatment.

Identifiants

pubmed: 35140874
doi: 10.48101/ujms.v127.7860
pii: 7860
pmc: PMC8788652
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2022 The Author(s). Published by Upsala Medical Society.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest.

Références

Hypertension. 1998 Mar;31(3):780-6
pubmed: 9495261
Neurology. 2001 Jun 26;56(12):1683-9
pubmed: 11425934
Stroke. 1998 Jan;29(1):75-81
pubmed: 9445332
Neurobiol Aging. 2000 Jan-Feb;21(1):49-55
pubmed: 10794848
Lancet Neurol. 2019 Oct;18(10):942-952
pubmed: 31444142
Brain. 2013 Sep;136(Pt 9):2697-706
pubmed: 23842566
JAMA Neurol. 2017 Oct 1;74(10):1246-1254
pubmed: 28783817
Lancet. 2017 Dec 16;390(10113):2673-2734
pubmed: 28735855
PLoS One. 2014 Mar 13;9(3):e91637
pubmed: 24626222
Arch Intern Med. 2003 May 12;163(9):1069-75
pubmed: 12742805
Neurology. 2005 Jan 25;64(2):277-81
pubmed: 15668425
JAMA. 2020 May 19;323(19):1934-1944
pubmed: 32427305
Lancet Neurol. 2011 Sep;10(9):819-28
pubmed: 21775213
Neurology. 2007 Dec 11;69(24):2197-204
pubmed: 17568013
Circulation. 2014 Oct 14;130(16):1407-14
pubmed: 25311618
Neurology. 2017 Dec 12;89(24):2447-2454
pubmed: 29117954
Hypertension. 2016 Dec;68(6):e67-e94
pubmed: 27977393
Lancet Neurol. 2014 Aug;13(8):788-94
pubmed: 25030513
Lancet. 1998 Oct 24;352(9137):1347-51
pubmed: 9802273
N Engl J Med. 2003 Mar 27;348(13):1215-22
pubmed: 12660385
Eur J Cardiovasc Nurs. 2006 Dec;5(4):275-9
pubmed: 16616876
Lakartidningen. 2006 Jul 12-25;103(28-29):2135-9
pubmed: 16895096
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Dement Geriatr Cogn Disord. 2011;31(6):460-6
pubmed: 21791923
BMC Public Health. 2011 Jun 09;11:450
pubmed: 21658213
Aging Clin Exp Res. 2007 Oct;19(5):381-9
pubmed: 18007116

Auteurs

Linn Moberg (L)

Centre for Clinical Research, Uppsala University, Västmanland County Hospital, Västerås, Sweden.

Jerzy Leppert (J)

Centre for Clinical Research, Uppsala University, Västmanland County Hospital, Västerås, Sweden.

Simon Liljeström (S)

Centre for Clinical Research, Uppsala University, Västmanland County Hospital, Västerås, Sweden.

Mattias Rehn (M)

Centre for Clinical Research, Uppsala University, Västmanland County Hospital, Västerås, Sweden.

Lena Kilander (L)

Department of Public Health and Caring Sciences/Geriatrics, Uppsala University, Uppsala, Sweden.

Abbas Chabok (A)

Centre for Clinical Research, Uppsala University, Västmanland County Hospital, Västerås, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH